Fate Therapeutics Inc (FATE)

R&D Expense Growth

11.94%

Quarterly · Period ending:

FATE logo

FATE R&D Expense Growth

Latest reported11.94%
FATE Quarterly R&D Growth (QoQ) (0.00% → 11.94%)
High-resolution chart · PNG

FATE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
11.944%
-14.3166%
-1.5984%
-5.8039%
-5.8553%
-13.3089%
-3.0043%
0.1329%
7.6732%
1.0121%
-7.1743%
-16.1488%
-37.7166%
-24.7296%
9.2386%
-1.8326%
12.7088%
3.7747%
30.8395%
10.6345%
7.0699%
15.0582%
27.002%
15.0924%
-8.9111%
16.1411%
8.6501%
7.2627%
22.016%
25.7751%
3.3585%
-18.9046%
46.5319%
16.0716%
15.26%
8.2124%
-0.4896%
27.8652%
-8.4362%
0.3244%
2.2001%
22.1425%
8.5948%
3.006%
6.3266%
18.1889%
-5.2696%
2.8226%
-12.2512%
49.1917%
-10.2724%
10.1402%
21.1774%
-25.6244%
2.6546%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.